[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002994:Clofibrate / Q000494:pharmacology / Q000627:therapeutic use; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects*; D011087:Polycythemia Vera / Q000188:drug therapy; D011458:Prostaglandins E / Q000494:pharmacology / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D003911:Dextrans; D011458:Prostaglandins E; D004176:Dipyridamole; D006493:Heparin; D002994:Clofibrate; D001241:Aspirin
Gli antiaggreganti piastrinici. Loro Possibilità di impiego nella patologia pediatrica.